CN104510726A - 一种用于清洁呼吸道系统的食盐干粉吸入剂 - Google Patents
一种用于清洁呼吸道系统的食盐干粉吸入剂 Download PDFInfo
- Publication number
- CN104510726A CN104510726A CN201310446107.4A CN201310446107A CN104510726A CN 104510726 A CN104510726 A CN 104510726A CN 201310446107 A CN201310446107 A CN 201310446107A CN 104510726 A CN104510726 A CN 104510726A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- formula
- diluent
- sal
- dry
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 16
- 210000002345 respiratory system Anatomy 0.000 title claims abstract description 15
- 150000003839 salts Chemical class 0.000 title abstract description 21
- 238000004140 cleaning Methods 0.000 title description 2
- 238000002360 preparation method Methods 0.000 claims abstract description 13
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 11
- 229930003231 vitamin Natural products 0.000 claims abstract description 10
- 239000011782 vitamin Substances 0.000 claims abstract description 10
- 235000013343 vitamin Nutrition 0.000 claims abstract description 10
- 229940088594 vitamin Drugs 0.000 claims abstract description 10
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 10
- 239000000203 mixture Substances 0.000 claims abstract description 4
- 239000002245 particle Substances 0.000 claims abstract 3
- OBRNDARFFFHCGE-QDSVTUBZSA-N arformoterol fumarate Chemical compound OC(=O)\C=C\C(O)=O.C1=CC(OC)=CC=C1C[C@@H](C)NC[C@H](O)C1=CC=C(O)C(NC=O)=C1.C1=CC(OC)=CC=C1C[C@@H](C)NC[C@H](O)C1=CC=C(O)C(NC=O)=C1 OBRNDARFFFHCGE-QDSVTUBZSA-N 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 15
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 12
- 239000003085 diluting agent Substances 0.000 claims description 10
- 229960000193 formoterol fumarate Drugs 0.000 claims description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 5
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 5
- 239000008101 lactose Substances 0.000 claims description 5
- 238000005507 spraying Methods 0.000 claims description 4
- 229960003512 nicotinic acid Drugs 0.000 claims description 3
- 239000000796 flavoring agent Substances 0.000 claims description 2
- 235000001968 nicotinic acid Nutrition 0.000 claims description 2
- 239000011664 nicotinic acid Substances 0.000 claims description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- 229930195725 Mannitol Natural products 0.000 claims 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 1
- 229930006000 Sucrose Natural products 0.000 claims 1
- 229930003779 Vitamin B12 Natural products 0.000 claims 1
- 229930003537 Vitamin B3 Natural products 0.000 claims 1
- 238000000498 ball milling Methods 0.000 claims 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims 1
- 239000006185 dispersion Substances 0.000 claims 1
- 235000019634 flavors Nutrition 0.000 claims 1
- 239000008103 glucose Substances 0.000 claims 1
- 239000000594 mannitol Substances 0.000 claims 1
- 235000010355 mannitol Nutrition 0.000 claims 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims 1
- 235000008160 pyridoxine Nutrition 0.000 claims 1
- 239000011677 pyridoxine Substances 0.000 claims 1
- 239000005720 sucrose Substances 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 235000019163 vitamin B12 Nutrition 0.000 claims 1
- 239000011715 vitamin B12 Substances 0.000 claims 1
- 235000019160 vitamin B3 Nutrition 0.000 claims 1
- 239000011708 vitamin B3 Substances 0.000 claims 1
- 235000019158 vitamin B6 Nutrition 0.000 claims 1
- 239000011726 vitamin B6 Substances 0.000 claims 1
- 229940011671 vitamin b6 Drugs 0.000 claims 1
- 210000004072 lung Anatomy 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 2
- 229940112141 dry powder inhaler Drugs 0.000 abstract 1
- 239000000443 aerosol Substances 0.000 description 13
- 230000002685 pulmonary effect Effects 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 230000008021 deposition Effects 0.000 description 6
- 239000008187 granular material Substances 0.000 description 5
- 210000004877 mucosa Anatomy 0.000 description 5
- 210000003097 mucus Anatomy 0.000 description 5
- 230000000474 nursing effect Effects 0.000 description 5
- 239000002775 capsule Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000004224 protection Effects 0.000 description 4
- 206010036790 Productive cough Diseases 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000000227 grinding Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000000241 respiratory effect Effects 0.000 description 3
- 230000029058 respiratory gaseous exchange Effects 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 230000004936 stimulating effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000009837 dry grinding Methods 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000000242 pagocytic effect Effects 0.000 description 2
- 208000023504 respiratory system disease Diseases 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 206010061876 Obstruction Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000018569 Respiratory Tract disease Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000003749 cleanliness Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 210000002175 goblet cell Anatomy 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 238000010297 mechanical methods and process Methods 0.000 description 1
- 230000005226 mechanical processes and functions Effects 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 238000001050 pharmacotherapy Methods 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000001533 respiratory mucosa Anatomy 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310446107.4A CN104510726A (zh) | 2013-09-27 | 2013-09-27 | 一种用于清洁呼吸道系统的食盐干粉吸入剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310446107.4A CN104510726A (zh) | 2013-09-27 | 2013-09-27 | 一种用于清洁呼吸道系统的食盐干粉吸入剂 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104510726A true CN104510726A (zh) | 2015-04-15 |
Family
ID=52786965
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310446107.4A Pending CN104510726A (zh) | 2013-09-27 | 2013-09-27 | 一种用于清洁呼吸道系统的食盐干粉吸入剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104510726A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106309367A (zh) * | 2015-06-26 | 2017-01-11 | 陈东浩 | 食盐气雾吸入剂及其制备方法和应用 |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1142190A (zh) * | 1994-02-25 | 1997-02-05 | 悉尼中部地区健康服务中心 | 引起气道狭窄和/或诱导痰产生的方法和装置 |
CN1348377A (zh) * | 1998-12-17 | 2002-05-08 | 希龙公司 | 用气溶胶化的抗生素治疗严重慢性支气管炎(支气管扩张症)的方法 |
CN1597558A (zh) * | 2004-07-19 | 2005-03-23 | 王成余 | 含纳米sod的水及其制备方法 |
CN1836747A (zh) * | 2006-03-23 | 2006-09-27 | 王�华 | 便携式盐疗器 |
CN101227912A (zh) * | 2005-06-14 | 2008-07-23 | 基利得科学公司 | 用于治疗肺炎和支气管收缩的作为类固醇和β-激动剂的协同前药的取代苯基磷酸酯 |
CN101317821A (zh) * | 2007-11-15 | 2008-12-10 | 陈晓东 | 适用于肺部给药的超细干粉颗粒及其制备方法 |
CN101657460A (zh) * | 2006-12-13 | 2010-02-24 | 基利得科学公司 | 用于治疗肺炎症和支气管收缩的作为抗炎性信号转导调节剂(AISTM’S)和β-激动剂的相互前药的单磷酸酯 |
CN102058566A (zh) * | 2010-12-24 | 2011-05-18 | 中国药科大学 | 一种冬凌草甲素类成分干粉吸入剂及其制备方法和用途 |
CN101384288B (zh) * | 2006-02-13 | 2012-09-05 | 雅戈泰克股份公司 | 干粉吸入器设备 |
-
2013
- 2013-09-27 CN CN201310446107.4A patent/CN104510726A/zh active Pending
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1142190A (zh) * | 1994-02-25 | 1997-02-05 | 悉尼中部地区健康服务中心 | 引起气道狭窄和/或诱导痰产生的方法和装置 |
CN1348377A (zh) * | 1998-12-17 | 2002-05-08 | 希龙公司 | 用气溶胶化的抗生素治疗严重慢性支气管炎(支气管扩张症)的方法 |
CN1597558A (zh) * | 2004-07-19 | 2005-03-23 | 王成余 | 含纳米sod的水及其制备方法 |
CN101227912A (zh) * | 2005-06-14 | 2008-07-23 | 基利得科学公司 | 用于治疗肺炎和支气管收缩的作为类固醇和β-激动剂的协同前药的取代苯基磷酸酯 |
CN101384288B (zh) * | 2006-02-13 | 2012-09-05 | 雅戈泰克股份公司 | 干粉吸入器设备 |
CN1836747A (zh) * | 2006-03-23 | 2006-09-27 | 王�华 | 便携式盐疗器 |
CN101657460A (zh) * | 2006-12-13 | 2010-02-24 | 基利得科学公司 | 用于治疗肺炎症和支气管收缩的作为抗炎性信号转导调节剂(AISTM’S)和β-激动剂的相互前药的单磷酸酯 |
CN101317821A (zh) * | 2007-11-15 | 2008-12-10 | 陈晓东 | 适用于肺部给药的超细干粉颗粒及其制备方法 |
CN102058566A (zh) * | 2010-12-24 | 2011-05-18 | 中国药科大学 | 一种冬凌草甲素类成分干粉吸入剂及其制备方法和用途 |
Non-Patent Citations (1)
Title |
---|
熊政: "岩盐气溶胶疗法在支气管哮喘治疗中的临床疗效分析", 《中国医疗前沿》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106309367A (zh) * | 2015-06-26 | 2017-01-11 | 陈东浩 | 食盐气雾吸入剂及其制备方法和应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1139384A (zh) | 糠酸毛他松在治疗呼吸道和肺部疾病中的用途 | |
CN1304290A (zh) | 雷洛昔芬的肺和鼻传递给药 | |
CN109999052B (zh) | β-烟酰胺单核苷酸或其前体在制备治疗或缓解呼吸障碍或疾病的药物中的用途 | |
Zheng et al. | Zhang | |
CN105726572A (zh) | 阿胶在制备治疗空气细颗粒物所致呼吸系统损伤药物或保健品中的用途 | |
CN111544385A (zh) | 一种鼻腔清洗液体浓缩剂 | |
WO2017080485A1 (zh) | 治疗呼吸系统疾病的药物组合物 | |
CN104510726A (zh) | 一种用于清洁呼吸道系统的食盐干粉吸入剂 | |
CN102302504A (zh) | 高纯度黄芩苷或黄芩素在制备吸入式平喘药物的应用 | |
CN103272083B (zh) | 用于预防和/或治疗哮喘的药物组合物、其制备方法及用途 | |
Tao et al. | Atomization method for verifying size effects of inhalable particles on lung damage of mice | |
CN104906237A (zh) | 一种中药组合物在制备治疗细颗粒造成肺损伤药物中的应用 | |
CN109771397B (zh) | 通过乳糖微粉预沉积改良肺部吸入用药的设备集成及方法 | |
CN101829154A (zh) | 防治哮喘的药物组合物 | |
WO2021156839A1 (en) | Composition in the form of powder containing an extract of cannabis sativa for the treatment of inflammations or infections or allergies of the respiratory system and /or hypersecretion of the mucus, and device for its dosage | |
CN107243024B (zh) | 一种双金连的药物组合物、一种双金连的雾化吸入用溶液及其制备方法和用途 | |
CN107281270A (zh) | 桑葚提取物在制备预防和治疗pm2.5所致肺损伤药物中的应用 | |
CN110960603A (zh) | 一种抗雾霾损伤组合物、其制备方法及使用方法 | |
CN111110634A (zh) | 一种磷酸氯喹吸入气雾剂及其制备方法 | |
CN104491059B (zh) | 一种浓缩型小儿咳喘灵口服液 | |
CN106309367A (zh) | 食盐气雾吸入剂及其制备方法和应用 | |
CN103784712A (zh) | 一种能够修复由于环境污染导致肺部损伤的保健品及其制备方法 | |
CN108771660A (zh) | 盐酸环丙沙星干粉吸入剂及其制备方法 | |
CN112245500B (zh) | 一种固肺中药组合物及其应用 | |
CN105769914A (zh) | 阿胶在制备抗雾霾药物或保健品中的用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: NINGBO PULMED BIOLOGICAL MEDICINE CO., LTD. Free format text: FORMER OWNER: ZHANG JINHUA Effective date: 20150506 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 250022 JINAN, SHANDONG PROVINCE TO: 315800 NINGBO, ZHEJIANG PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20150506 Address after: Beilun District of Zhejiang city in Ningbo Province, 315800 West Road No. 503 building two Aquila A2 Applicant after: Ningbo Pumaite Biological Medicine Co Ltd Address before: 250022, F16 new unit, sunshine 100 international new town, Shandong, Ji'nan 602 Applicant before: Zhang Jinhua |
|
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150415 |
|
RJ01 | Rejection of invention patent application after publication |